Biorocks
PrivateLast Round
Series A
Extension
Jan 4, 2023
Total Funding Raised
$6.3M
Company Overview
Biorocks is a biotechnology company that develops and manufactures automated, microfluidics-based systems for embryo cryopreservation and warming to improve the consistency and efficiency of assisted reproductive technology.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biorocks Comparables
Compare Biorocks with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AutoIVF, Inc. | 84% | |
| FertileSafe Ltd. | 84% | |
| Overture Life | 82% |
Biorocks Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jan 4, 2023 | ||||
| Series A | Oct 1, 2022 | ||||
| Early Funding | Jan 1, 2022 | ||||
| Early Funding | Aug 1, 2021 | ||||
| Angel | Jun 1, 2021 |
Biorocks Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shenzhen Credit Guarantee Group | Series A Extension |
| 清科资本 | Series A Extension |
| Shenzhen Sunhope Investment Development Co., Ltd. | Early Funding |
| 联想创投集团 (Lenovo Capital and Incubator Group) | Series A |
| Zero2IPO Venture Capital | Early Funding |
| Zero2IPO Group | Early Funding |
| Shenzhen HTI Group | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 4, 2023
$3M round led by Qingke Capital
- Jan 1, 2022
$3.1M raised from Zero2IPO Group and others.
Biorocks Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Biorocks's valuation, stock price, and market status.
Is Biorocks a public or private company?
Biorocks is a private company.
What is the current stock price of Biorocks?
Biorocks is a private company with no public stock price. No recent secondary market data is available.
How much is Biorocks worth (valuation)?
Valuation information for Biorocks is not publicly available.
Can I buy Biorocks stock?
Biorocks shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Biorocks's last funding round?
Biorocks's most recent funding round was Series A Extension on January 4, 2023.
Who are the main investors in Biorocks?
Key investors in Biorocks include 清科资本, 联想创投集团 (Lenovo Capital and Incubator Group).
Will Biorocks IPO soon?
No public IPO plans have been announced for Biorocks.
How can I track Biorocks secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Biorocks's secondary market activity and sign up for updates.